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The tumor suppressor CYLD gene encodes a deubiquiti-
nating enzyme that removes lys-63-linked ubiquitin chains.
CYLD regulates, by its catalytic domain, NF-kB, c-Jun
kinase and Wnt/b-catenin signalling pathways. When
mutated in its catalytic domain CYLD cause skin appen-
dages tumors as in familial cylindromatosis. We have
found CYLD as a partner of the centrosomal protein
CAP350 in immunoprecipitation experiments followed by
mass spectrometry. CAP350 was shown to play a role in
microtubule stabilization (Hoppeler-Leber et al, 2007).
Here, we show that CYLD localizes to the centrosome in
cells and is enriched in purified centrosomes. To under-
stand the functional interaction between CYLD and
CAP350, we studied mice carrying deletion of part of the
deubiquitinase domain and mimicking the human pathol-
ogy. These homozygous mice cyld (del17/del17) die perina-
tally due to respiratory dysfunction and exhibit immature
lung phenotype. To test if CYLD is involved in ciliogenesis,
we studied the presence of motile cilia in the trachea. Cyld
(del17/del17) embryo tracheas exhibit a decreased number
of ciliated cells compared to wild type ones of the same
litter. In addition, these ciliated cells have fewer and shorter
cilia. Similar results were obtained on ependymal cell cul-
ture. Transmission electron micrographs demonstrate that
most of the basal bodies fail to anchor to the plasma mem-
brane. We demonstrate that in MEFs derived from cyld
(del17/del17) embryo, CYLD and CAP350 do not longer
interact in contrast to MEFs derived from wild type
embryo. In addition, these mutant MEFs exhibit primary
cilia growth defect compared to MEFs derived from wild
type mice.
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